Kilitch Drugs (India) Limited (NSE:KILITCH)
189.22
+6.95 (3.81%)
May 25, 2026, 10:30 AM IST
Kilitch Drugs (India) Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 167.76 | 98.01 | 189.62 | 198.46 | 100.62 |
Short-Term Investments | 519.63 | 495.65 | 501.09 | 393.31 | 472.34 |
Cash & Short-Term Investments | 687.39 | 593.66 | 690.71 | 591.77 | 572.96 |
Cash Growth | 15.79% | -14.05% | 16.72% | 3.28% | 17.17% |
Accounts Receivable | 1,202 | 847.39 | 632.24 | 542.87 | 414.12 |
Other Receivables | 0.33 | 0.32 | 0.34 | 0.22 | 0.2 |
Receivables | 1,202 | 847.71 | 632.58 | 543.09 | 414.32 |
Inventory | 115.21 | 215.78 | 55.82 | 24.07 | 52.88 |
Prepaid Expenses | - | 1.98 | 0.86 | 1.58 | 0.5 |
Other Current Assets | 217.26 | 80.04 | 79.97 | 103.53 | 100.39 |
Total Current Assets | 2,222 | 1,739 | 1,460 | 1,264 | 1,141 |
Property, Plant & Equipment | 1,887 | 928.19 | 481.2 | 473.58 | 464.03 |
Long-Term Investments | 228.82 | 228.6 | 228.47 | 226.78 | 260.68 |
Goodwill | 176.93 | 185.36 | 193.79 | 202.21 | 210.64 |
Other Intangible Assets | 2.64 | 3.52 | 4.44 | 2.63 | 2.34 |
Long-Term Deferred Tax Assets | 45.82 | 28.79 | 25.63 | 19.78 | 15.12 |
Other Long-Term Assets | 14.18 | 14.22 | 7.15 | 6.21 | 4.63 |
Total Assets | 4,577 | 3,128 | 2,401 | 2,195 | 2,098 |
Accounts Payable | 796.47 | 541.57 | 255.89 | 408.75 | 428.69 |
Accrued Expenses | - | 17.43 | 15.97 | 16.44 | 14.48 |
Short-Term Debt | 301.06 | 216.54 | 316.47 | 221.94 | 204.32 |
Current Income Taxes Payable | 65.66 | 66.86 | 53.05 | 40.39 | 43.96 |
Other Current Liabilities | 52.81 | 0.7 | 0.78 | 1.22 | 1.34 |
Total Current Liabilities | 1,216 | 843.1 | 642.16 | 688.73 | 692.79 |
Long-Term Debt | 586.04 | 277.7 | - | - | - |
Pension & Post-Retirement Benefits | - | 2.45 | 1.72 | 0.68 | 2.75 |
Other Long-Term Liabilities | 6.79 | - | - | - | - |
Total Liabilities | 1,809 | 1,123 | 643.88 | 689.41 | 695.55 |
Common Stock | 349.62 | 160.82 | 160.82 | 155.82 | 155.82 |
Additional Paid-In Capital | - | 466.84 | 466.84 | 383.26 | 383.26 |
Retained Earnings | - | 1,267 | 1,000 | 854.29 | 749.81 |
Comprehensive Income & Other | 2,447 | 128.32 | 134.95 | 122.6 | 101.97 |
Total Common Equity | 2,797 | 2,023 | 1,763 | 1,516 | 1,391 |
Minority Interest | -27.86 | -18.71 | -6.18 | -10.17 | 12.07 |
Shareholders' Equity | 2,769 | 2,005 | 1,757 | 1,506 | 1,403 |
Total Liabilities & Equity | 4,577 | 3,128 | 2,401 | 2,195 | 2,098 |
Total Debt | 887.09 | 494.24 | 316.47 | 221.94 | 204.32 |
Net Cash (Debt) | -199.7 | 99.42 | 374.25 | 369.83 | 368.64 |
Net Cash Growth | - | -73.44% | 1.19% | 0.32% | 8.11% |
Net Cash Per Share | -5.90 | 3.09 | 11.75 | 11.87 | 11.84 |
Filing Date Shares Outstanding | 34.24 | 32.16 | 32.16 | 31.16 | 31.16 |
Total Common Shares Outstanding | 34.24 | 32.16 | 32.16 | 31.16 | 31.16 |
Working Capital | 1,006 | 896.06 | 817.77 | 575.3 | 448.25 |
Book Value Per Share | 81.67 | 62.90 | 54.81 | 48.64 | 44.63 |
Tangible Book Value | 2,617 | 1,834 | 1,565 | 1,311 | 1,178 |
Tangible Book Value Per Share | 76.43 | 57.03 | 48.65 | 42.07 | 37.80 |
Land | - | 86.78 | 86.78 | 86.13 | 86.13 |
Buildings | - | 41.72 | 40.02 | 40.02 | 39.43 |
Machinery | - | 621.67 | 568.69 | 561.19 | 529.87 |
Construction In Progress | - | 472.95 | 59.65 | 36.19 | 31.61 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.